Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden. / Olsson, Ann; Bouaoun, Liacine; Auvinen, Anssi; Feychting, Maria; Johansen, Christoffer; Mathiesen, Tiit; Melin, Beatrice; Lahkola, Anna; Larjavaara, Suvi; Villegier, Anne-Sophie; Byrnes, Graham; Deltour, Isabelle; Schüz, Joachim.
In: Journal of Neuro-Oncology, Vol. 141, No. 1, 01.2019, p. 139-149.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden
AU - Olsson, Ann
AU - Bouaoun, Liacine
AU - Auvinen, Anssi
AU - Feychting, Maria
AU - Johansen, Christoffer
AU - Mathiesen, Tiit
AU - Melin, Beatrice
AU - Lahkola, Anna
AU - Larjavaara, Suvi
AU - Villegier, Anne-Sophie
AU - Byrnes, Graham
AU - Deltour, Isabelle
AU - Schüz, Joachim
PY - 2019/1
Y1 - 2019/1
N2 - PURPOSE: Gliomas are the most common cancer of the brain, with a poor prognosis in particular for glioblastoma. In 2014, a study suggested reduced survival in relation to latency of mobile phone use among glioblastoma patients. A joint epidemiological/experimental project to study effects of RF-EMF on tumor development and progression was established. The current analysis relates to the epidemiological part and addresses whether pre-diagnostic mobile phone use was associated with survival among glioma patients.METHODS: Glioma cases (n = 806) previously enrolled in a collaborative population-based case-control study in Denmark, Finland and Sweden were followed up for survival. Vital status, date of death, date of emigration, or date last known to be alive was obtained based on registry linkages with a unique personal ID in each country. Cox regression models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI) stratified by country. Covariates investigated were sex, age, education, histology, treatment, anatomic location and marital status.RESULTS: No indication of reduced survival among glioblastoma patients was observed for various measures of mobile phone use (ever regular use, time since start of regular use, cumulative call time overall or in the last 12 months) relative to no or non-regular use. All significant associations suggested better survival for mobile phone users. Results were similar for high-grade and low-grade gliomas.CONCLUSIONS: We found no evidence of reduced survival among glioma patients in relation to previous mobile phone use.
AB - PURPOSE: Gliomas are the most common cancer of the brain, with a poor prognosis in particular for glioblastoma. In 2014, a study suggested reduced survival in relation to latency of mobile phone use among glioblastoma patients. A joint epidemiological/experimental project to study effects of RF-EMF on tumor development and progression was established. The current analysis relates to the epidemiological part and addresses whether pre-diagnostic mobile phone use was associated with survival among glioma patients.METHODS: Glioma cases (n = 806) previously enrolled in a collaborative population-based case-control study in Denmark, Finland and Sweden were followed up for survival. Vital status, date of death, date of emigration, or date last known to be alive was obtained based on registry linkages with a unique personal ID in each country. Cox regression models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI) stratified by country. Covariates investigated were sex, age, education, histology, treatment, anatomic location and marital status.RESULTS: No indication of reduced survival among glioblastoma patients was observed for various measures of mobile phone use (ever regular use, time since start of regular use, cumulative call time overall or in the last 12 months) relative to no or non-regular use. All significant associations suggested better survival for mobile phone users. Results were similar for high-grade and low-grade gliomas.CONCLUSIONS: We found no evidence of reduced survival among glioma patients in relation to previous mobile phone use.
KW - Adolescent
KW - Adult
KW - Aged
KW - Brain Neoplasms/mortality
KW - Case-Control Studies
KW - Cell Phone Use
KW - Denmark/epidemiology
KW - Female
KW - Finland/epidemiology
KW - Glioma/mortality
KW - Humans
KW - Male
KW - Middle Aged
KW - Radio Waves/adverse effects
KW - Sweden/epidemiology
KW - Young Adult
U2 - 10.1007/s11060-018-03019-5
DO - 10.1007/s11060-018-03019-5
M3 - Journal article
C2 - 30421160
VL - 141
SP - 139
EP - 149
JO - Journal of Neuro-Oncology
JF - Journal of Neuro-Oncology
SN - 0167-594X
IS - 1
ER -
ID: 235472383